Global and Japan In Vitro Toxicity Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Toxicity Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Dose Response
1.2.3 Threshold Response
1.3 Market by Application
1.3.1 Global In Vitro Toxicity Market Share by Application: 2020 VS 2026
1.3.2 Distribution
1.3.3 Excretion
1.3.4 Metabolism
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Toxicity Market Perspective (2015-2026)
2.2 Global In Vitro Toxicity Growth Trends by Regions
2.2.1 In Vitro Toxicity Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 In Vitro Toxicity Historic Market Share by Regions (2015-2020)
2.2.3 In Vitro Toxicity Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Toxicity Players by Market Size
3.1.1 Global Top In Vitro Toxicity Players by Revenue (2015-2020)
3.1.2 Global In Vitro Toxicity Revenue Market Share by Players (2015-2020)
3.2 Global In Vitro Toxicity Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In Vitro Toxicity Revenue
3.4 Global In Vitro Toxicity Market Concentration Ratio
3.4.1 Global In Vitro Toxicity Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Toxicity Revenue in 2019
3.5 Key Players In Vitro Toxicity Area Served
3.6 Key Players In Vitro Toxicity Product Solution and Service
3.7 Date of Enter into In Vitro Toxicity Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In Vitro Toxicity Breakdown Data by Type (2015-2026)
4.1 Global In Vitro Toxicity Historic Market Size by Type (2015-2020)
4.2 Global In Vitro Toxicity Forecasted Market Size by Type (2021-2026)
5 In Vitro Toxicity Breakdown Data by Application (2015-2026)
5.1 Global In Vitro Toxicity Historic Market Size by Application (2015-2020)
5.2 Global In Vitro Toxicity Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America In Vitro Toxicity Market Size (2015-2026)
6.2 North America In Vitro Toxicity Market Size by Type (2015-2020)
6.3 North America In Vitro Toxicity Market Size by Application (2015-2020)
6.4 North America In Vitro Toxicity Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe In Vitro Toxicity Market Size (2015-2026)
7.2 Europe In Vitro Toxicity Market Size by Type (2015-2020)
7.3 Europe In Vitro Toxicity Market Size by Application (2015-2020)
7.4 Europe In Vitro Toxicity Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China In Vitro Toxicity Market Size (2015-2026)
8.2 China In Vitro Toxicity Market Size by Type (2015-2020)
8.3 China In Vitro Toxicity Market Size by Application (2015-2020)
8.4 China In Vitro Toxicity Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan In Vitro Toxicity Market Size (2015-2026)
9.2 Japan In Vitro Toxicity Market Size by Type (2015-2020)
9.3 Japan In Vitro Toxicity Market Size by Application (2015-2020)
9.4 Japan In Vitro Toxicity Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia In Vitro Toxicity Market Size (2015-2026)
10.2 Southeast Asia In Vitro Toxicity Market Size by Type (2015-2020)
10.3 Southeast Asia In Vitro Toxicity Market Size by Application (2015-2020)
10.4 Southeast Asia In Vitro Toxicity Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Details
11.1.2 Agilent Technologies Business Overview
11.1.3 Agilent Technologies In Vitro Toxicity Introduction
11.1.4 Agilent Technologies Revenue in In Vitro Toxicity Business (2015-2020))
11.1.5 Agilent Technologies Recent Development
11.2 Covance
11.2.1 Covance Company Details
11.2.2 Covance Business Overview
11.2.3 Covance In Vitro Toxicity Introduction
11.2.4 Covance Revenue in In Vitro Toxicity Business (2015-2020)
11.2.5 Covance Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In Vitro Toxicity Introduction
11.3.4 Bio-Rad Laboratories Revenue in In Vitro Toxicity Business (2015-2020)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 General Electric
11.4.1 General Electric Company Details
11.4.2 General Electric Business Overview
11.4.3 General Electric In Vitro Toxicity Introduction
11.4.4 General Electric Revenue in In Vitro Toxicity Business (2015-2020)
11.4.5 General Electric Recent Development
11.5 Eurofins Scientific
11.5.1 Eurofins Scientific Company Details
11.5.2 Eurofins Scientific Business Overview
11.5.3 Eurofins Scientific In Vitro Toxicity Introduction
11.5.4 Eurofins Scientific Revenue in In Vitro Toxicity Business (2015-2020)
11.5.5 Eurofins Scientific Recent Development
11.6 BioReliance
11.6.1 BioReliance Company Details
11.6.2 BioReliance Business Overview
11.6.3 BioReliance In Vitro Toxicity Introduction
11.6.4 BioReliance Revenue in In Vitro Toxicity Business (2015-2020)
11.6.5 BioReliance Recent Development
11.7 Charles River Laboratories International
11.7.1 Charles River Laboratories International Company Details
11.7.2 Charles River Laboratories International Business Overview
11.7.3 Charles River Laboratories International In Vitro Toxicity Introduction
11.7.4 Charles River Laboratories International Revenue in In Vitro Toxicity Business (2015-2020)
11.7.5 Charles River Laboratories International Recent Development
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific In Vitro Toxicity Introduction
11.8.4 Thermo Fisher Scientific Revenue in In Vitro Toxicity Business (2015-2020)
11.8.5 Thermo Fisher Scientific Recent Development
11.9 Catalent
11.9.1 Catalent Company Details
11.9.2 Catalent Business Overview
11.9.3 Catalent In Vitro Toxicity Introduction
11.9.4 Catalent Revenue in In Vitro Toxicity Business (2015-2020)
11.9.5 Catalent Recent Development
11.10 Cyprotex
11.10.1 Cyprotex Company Details
11.10.2 Cyprotex Business Overview
11.10.3 Cyprotex In Vitro Toxicity Introduction
11.10.4 Cyprotex Revenue in In Vitro Toxicity Business (2015-2020)
11.10.5 Cyprotex Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global In Vitro Toxicity Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Dose Response
Table 4. Key Players of Threshold Response
Table 5. Global In Vitro Toxicity Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global In Vitro Toxicity Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global In Vitro Toxicity Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global In Vitro Toxicity Market Share by Regions (2015-2020)
Table 9. Global In Vitro Toxicity Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global In Vitro Toxicity Market Share by Regions (2021-2026)
Table 11. In Vitro Toxicity Market Market Trends
Table 12. In Vitro Toxicity Market Drivers
Table 13. In Vitro Toxicity Market Challenges
Table 14. In Vitro Toxicity Market Restraints
Table 15. Global In Vitro Toxicity Revenue by Players (2015-2020) (US$ Million)
Table 16. Global In Vitro Toxicity Market Share by Players (2015-2020)
Table 17. Global Top In Vitro Toxicity Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Toxicity as of 2019)
Table 18. Global In Vitro Toxicity by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In Vitro Toxicity Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 23. Global In Vitro Toxicity Market Size Share by Type (2015-2020)
Table 24. Global In Vitro Toxicity Revenue Market Share by Type (2021-2026)
Table 25. Global In Vitro Toxicity Market Size Share by Application (2015-2020)
Table 26. Global In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 27. Global In Vitro Toxicity Market Size Share by Application (2021-2026)
Table 28. North America In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 29. North America In Vitro Toxicity Market Share by Type (2015-2020)
Table 30. North America In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 31. North America In Vitro Toxicity Market Share by Application (2015-2020)
Table 32. North America In Vitro Toxicity Market Size by Country (US$ Million) (2015-2020)
Table 33. North America In Vitro Toxicity Market Share by Country (2015-2020)
Table 34. Europe In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe In Vitro Toxicity Market Share by Type (2015-2020)
Table 36. Europe In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe In Vitro Toxicity Market Share by Application (2015-2020)
Table 38. Europe In Vitro Toxicity Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe In Vitro Toxicity Market Share by Country (2015-2020)
Table 40. China In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 41. China In Vitro Toxicity Market Share by Type (2015-2020)
Table 42. China In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 43. China In Vitro Toxicity Market Share by Application (2015-2020)
Table 44. China In Vitro Toxicity Market Size by Region (US$ Million) (2015-2020)
Table 45. China In Vitro Toxicity Market Share by Region (2015-2020)
Table 46. Japan In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan In Vitro Toxicity Market Share by Type (2015-2020)
Table 48. Japan In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan In Vitro Toxicity Market Share by Application (2015-2020)
Table 50. Japan In Vitro Toxicity Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan In Vitro Toxicity Market Share by Country (2015-2020)
Table 52. Southeast Asia In Vitro Toxicity Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia In Vitro Toxicity Market Share by Type (2015-2020)
Table 54. Southeast Asia In Vitro Toxicity Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia In Vitro Toxicity Market Share by Application (2015-2020)
Table 56. Southeast Asia In Vitro Toxicity Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia In Vitro Toxicity Market Share by Country (2015-2020)
Table 58. Agilent Technologies Company Details
Table 59. Agilent Technologies Business Overview
Table 60. Agilent Technologies Product
Table 61. Agilent Technologies Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 62. Agilent Technologies Recent Development
Table 63. Covance Company Details
Table 64. Covance Business Overview
Table 65. Covance Product
Table 66. Covance Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 67. Covance Recent Development
Table 68. Bio-Rad Laboratories Company Details
Table 69. Bio-Rad Laboratories Business Overview
Table 70. Bio-Rad Laboratories Product
Table 71. Bio-Rad Laboratories Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 72. Bio-Rad Laboratories Recent Development
Table 73. General Electric Company Details
Table 74. General Electric Business Overview
Table 75. General Electric Product
Table 76. General Electric Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 77. General Electric Recent Development
Table 78. Eurofins Scientific Company Details
Table 79. Eurofins Scientific Business Overview
Table 80. Eurofins Scientific Product
Table 81. Eurofins Scientific Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 82. Eurofins Scientific Recent Development
Table 83. BioReliance Company Details
Table 84. BioReliance Business Overview
Table 85. BioReliance Product
Table 86. BioReliance Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 87. BioReliance Recent Development
Table 88. Charles River Laboratories International Company Details
Table 89. Charles River Laboratories International Business Overview
Table 90. Charles River Laboratories International Product
Table 91. Charles River Laboratories International Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 92. Charles River Laboratories International Recent Development
Table 93. Thermo Fisher Scientific Business Overview
Table 94. Thermo Fisher Scientific Product
Table 95. Thermo Fisher Scientific Company Details
Table 96. Thermo Fisher Scientific Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 97. Thermo Fisher Scientific Recent Development
Table 98. Catalent Company Details
Table 99. Catalent Business Overview
Table 100. Catalent Product
Table 101. Catalent Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 102. Catalent Recent Development
Table 103. Cyprotex Company Details
Table 104. Cyprotex Business Overview
Table 105. Cyprotex Product
Table 106. Cyprotex Revenue in In Vitro Toxicity Business (2015-2020) (US$ Million)
Table 107. Cyprotex Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global In Vitro Toxicity Market Share by Type: 2020 VS 2026
Figure 2. Dose Response Features
Figure 3. Threshold Response Features
Figure 4. Global In Vitro Toxicity Market Share by Application: 2020 VS 2026
Figure 5. Distribution Case Studies
Figure 6. Excretion Case Studies
Figure 7. Metabolism Case Studies
Figure 8. In Vitro Toxicity Report Years Considered
Figure 9. Global In Vitro Toxicity Market Size (US$ Million), YoY Growth 2015-2026
Figure 10. Global In Vitro Toxicity Market Share by Regions: 2020 VS 2026
Figure 11. Global In Vitro Toxicity Market Share by Regions (2021-2026)
Figure 12. Global In Vitro Toxicity Market Share by Players in 2019
Figure 13. Global Top In Vitro Toxicity Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In Vitro Toxicity as of 2019
Figure 14. The Top 10 and 5 Players Market Share by In Vitro Toxicity Revenue in 2019
Figure 15. North America In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. United States In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Canada In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Europe In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. Germany In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. France In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. U.K. In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Italy In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Russia In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Nordic In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Rest of Europe In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Asia-Pacific In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. China In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Japan In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. South Korea In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Southeast Asia In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. India In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Australia In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Rest of Asia-Pacific In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Latin America In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Mexico In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Brazil In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Middle East & Africa In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Turkey In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Saudi Arabia In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. UAE In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Rest of Middle East & Africa In Vitro Toxicity Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Agilent Technologies Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 43. Covance Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 44. Bio-Rad Laboratories Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 45. General Electric Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 46. Eurofins Scientific Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 47. BioReliance Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 48. Charles River Laboratories International Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 49. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 50. Catalent Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 51. Cyprotex Revenue Growth Rate in In Vitro Toxicity Business (2015-2020)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed